Given that the immunoregulatory function of MSCs against several inflammatory diseases was augmented by the introduction of SOD3 into cells, in the present study, we sought to verify the combined therapeutic efficacy of SOD3 and MSCs in IBD. This evidence concerns the gene SOD3 and inflammatory bowel disease.